Ovid Therapeutics Inc (OVID) — Cash Flow Reinvestment Rate
Ovid Therapeutics Inc (OVID) has a Cash Flow Reinvestment Rate of 0.00x as of March 2021, reinvesting $23.03K (capex $11.51K plus investments $-11.51K) from operating cash flow of $160.90 Million. See OVID cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ovid Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Ovid Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see OVID cash flow metrics.
Annual Cash Flow Reinvestment Rate for Ovid Therapeutics Inc (2021–2021)
Year-by-year capital reinvestment analysis for Ovid Therapeutics Inc. See financial agility of Ovid Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.02x | $1.82 Million | $118.61 Million | $189.41K | — |